Skip to content
← All startups
SimBioSys logo

SimBioSys

Series A

Provider of AI-based decision-making and cancer diagnosis tool for healthcare professionals. The company has developed TumorScope a digital software that uses AI-based technology and supercomputing to model the behavior of cancer in humans for diagnosis. It has tools for tumor visual on from patients MRI, PET, or other radiology scans. TumorScope software provides predictions of the tumor pre-treatment for lung…

HealthTech · Clinical Labs IT · Chicago, United States · EST 2016

About

Provider of AI-based decision-making and cancer diagnosis tool for healthcare professionals. The company has developed TumorScope a digital software that uses AI-based technology and supercomputing to model the behavior of cancer in humans for diagnosis. It has tools for tumor visual on from patients MRI, PET, or other radiology scans. TumorScope software provides predictions of the tumor pre-treatment for lung cancer, prostate cancer, and breast cancer.

Institutional investors

Genoa VenturesAV8 VenturesMayo ClinicHeritage GroupNorthpond VenturesKleinmuntz Associates

Latest coverage

📰 See all funding news — keep up with the raises that set comps.

Investor directory

🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.

Raising like SimBioSys?

Analyze your pitch deck before your next raise.

Analyze My Deck →